Assignee
CELERA CORP
US·68 granted patents·79 pending applications·805 citations·filing 2003–2022
Top patents by PatentIndex Score
147 records- 0197US7582441B1Methods and compositions for treating and diagnosing diseaseCELERA CORP·Filed 2006·Granted Sep 1, 2009·26 cites·3 claims
- 0296US7608413B1Kidney disease targets and uses thereofCELERA CORP·Filed 2007·Granted Oct 27, 2009·88 cites·4 claims
- 0396US7473531B1Pancreatic cancer targets and uses thereofCELERA CORP·Filed 2004·Granted Jan 6, 2009·141 cites·3 claims
- 0495US7842467B1Breast disease targets and uses thereofCELERA CORP·Filed 2008·Granted Nov 30, 2010·105 cites·3 claims
- 0595US7842466B1Colon disease targets and uses thereofCELERA CORP·Filed 2008·Granted Nov 30, 2010·38 cites·3 claims
- 0695US7807392B1Lung disease targets and uses thereofCELERA CORP·Filed 2007·Granted Oct 5, 2010·74 cites·5 claims
- 0794US7993833B2Genetic polymorphisms associated with psoriasis, methods of detection and uses thereofCELERA CORP·Filed 2007·Granted Aug 9, 2011·15 cites·24 claims
- 0894US7781168B2Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereofCELERA CORP·Filed 2008·Granted Aug 24, 2010·22 cites·50 claims
- 0994US7521195B1Lung disease targets and uses thereofCELERA CORP·Filed 2006·Granted Apr 21, 2009·38 cites·3 claims
- 1093US10301679B2Genetic polymorphisms, associated with rheumatoid arthritis, methods of detection and uses thereofCELERA CORP·Filed 2016·Granted May 28, 2019·7 cites·26 claims
- 1193US8975022B2Genetic polymorphisms associated with psoriasis, methdos of detection and uses thereofCELERA CORP·Filed 2012·Granted Mar 10, 2015·9 cites·39 claims
- 1292US9371565B2Genetic polymorphisms associated with psoriasis, methods of detection and uses thereofCELERA CORP·Filed 2015·Granted Jun 21, 2016·11 cites·24 claims
- 1392US7842291B1Methods and compositions for diagnosing and treating diseasesCELERA CORP·Filed 2007·Granted Nov 30, 2010·14 cites·4 claims
- 1492US7482117B2Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereofCELERA CORP·Filed 2003·Granted Jan 27, 2009·32 cites·24 claims
- 1591US7998689B2Detection of CXADR protein for diagnosis of kidney cancerCELERA CORP·Filed 2009·Granted Aug 16, 2011·15 cites·3 claims
- 1691US7892760B2Lung cancer markers, and uses thereofCELERA CORP·Filed 2008·Granted Feb 22, 2011·16 cites·39 claims
- 1791US7820380B2Genetic polymorphisms associated with liver fibrosisCELERA CORP·Filed 2005·Granted Oct 26, 2010·14 cites·13 claims
- 1890US8632987B2Methods and compositions for treating and diagnosing diseasesCELERA CORP·Filed 2012·Granted Jan 21, 2014·5 cites·5 claims
- 1989US11105806B2Lung cancer markers and uses thereofCELERA CORP·Filed 2019·Granted Aug 31, 2021·2 cites·31 claims
- 2088US10006088B2Genetic polymorphisms associated with psoriasis, methods of detection and uses thereofCELERA CORP·Filed 2016·Granted Jun 26, 2018·2 cites·24 claims
- 2188US7833706B2Genetic polymorphisms associated with rheumatoid arthritis, methods of detection and uses thereofCELERA CORP·Filed 2004·Granted Nov 16, 2010·30 cites·20 claims
- 2286US7816083B2Genetic polymorphisms associated with neurodegenerative diseases, methods of detection and uses thereofCELERA CORP·Filed 2008·Granted Oct 19, 2010·5 cites·32 claims
- 2386US7695916B2Genetic polymorphisms associated with coronary events and drug response, methods of detection and uses thereofCELERA CORP·Filed 2008·Granted Apr 13, 2010·7 cites·25 claims
- 2486US7625699B2Genetic polymorphisms associated with coronary stenosis, methods of detection and uses thereofCELERA CORP·Filed 2004·Granted Dec 1, 2009·22 cites·27 claims
- 2585US10113198B2Genetic polymorphisms associated with rheumatoid arthritis, methods of detection and uses thereofCELERA CORP·Filed 2016·Granted Oct 30, 2018·2 cites·19 claims
- 2685US7863021B2Genetic polymorphisms associated with rheumatoid arthritis, methods of detection and uses thereofCELERA CORP·Filed 2008·Granted Jan 4, 2011·9 cites·31 claims
- 2785US7651840B2Genetic polymorphisms associated with Alzheimer's disease, methods of detection and uses thereofCELERA CORP·Filed 2007·Granted Jan 26, 2010·8 cites·30 claims
- 2884US7727725B2Genetic polymorphisms associated with liver fibrosis, methods of detection and uses thereofCELERA CORP·Filed 2007·Granted Jun 1, 2010·3 cites·43 claims
- 2983US8039212B2Genetic polymorphisms associated with liver fibrosis, methods of detection and uses thereofCELERA CORP·Filed 2008·Granted Oct 18, 2011·2 cites·35 claims
- 3083US7960100B1Colon cancer targets and uses thereofCELERA CORP·Filed 2008·Granted Jun 14, 2011·4 cites·3 claims
- 3182US10435749B2Genetic polymorphisms associated with coronary events and drug response, methods of detection and uses thereofCELERA CORP·Filed 2016·Granted Oct 8, 2019·2 cites·18 claims
- 3282US7799530B2Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereofCELERA CORP·Filed 2006·Granted Sep 21, 2010·4 cites·39 claims
- 3381US12077825B2Genetic polymorphisms associated with stroke, methods of detection and uses thereofCELERA CORP·Filed 2022·Granted Sep 3, 2024·0 cites·11 claims
- 3481US10338075B2Lung cancer markers and uses thereofCELERA CORP·Filed 2016·Granted Jul 2, 2019·2 cites·35 claims
- 3581US9090682B2Methods and compositions for treating and diagnosing diseasesCELERA CORP·Filed 2013·Granted Jul 28, 2015·3 cites·8 claims
- 3681US7695911B2Genetic polymorphisms associated with Alzheimer's Disease, methods of detection and uses thereofCELERA CORP·Filed 2006·Granted Apr 13, 2010·2 cites·36 claims
- 3781US7695915B2Molecular prognostic signature for predicting breast cancer distant metastasis, and uses thereofCELERA CORP·Filed 2008·Granted Apr 13, 2010·2 cites·23 claims
- 3880US11041209B2Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereofCELERA CORP·Filed 2019·Granted Jun 22, 2021·0 cites·17 claims
- 3980US10131949B2Genetic polymorphisms associated with psoriasis, methods of detection and uses thereofCELERA CORP·Filed 2015·Granted Nov 20, 2018·2 cites·24 claims
- 4080US7977052B2Genetic polymorphisms associated with coronary heart disease, methods of detection and uses thereofCELERA CORP·Filed 2006·Granted Jul 12, 2011·2 cites·41 claims
- 4179US10584384B2Genetic polymorphisms associated with cardiovascular diseases, methods of detection and uses thereofCELERA CORP·Filed 2017·Granted Mar 10, 2020·2 cites·13 claims
- 4279US9932637B2Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereofCELERA CORP·Filed 2016·Granted Apr 3, 2018·2 cites·25 claims
- 4379US7910303B2Genetic polymorphisms associated with venous thrombosis, methods of detection and uses thereofCELERA CORP·Filed 2007·Granted Mar 22, 2011·3 cites·30 claims
- 4479US7611703B1Kidney disease targets and uses thereofCELERA CORP·Filed 2007·Granted Nov 3, 2009·4 cites·5 claims
- 4578US11827937B2Genetic polymorphisms associated with statin response and cardiovascular diseases, methods of detection and uses thereofCELERA CORP·Filed 2019·Granted Nov 28, 2023·0 cites·4 claims
- 4678US11697850B2Polymorphism in the Apo(a) gene predict responsiveness to acetylsalicylic acid treatmentCELERA CORP·Filed 2019·Granted Jul 11, 2023·0 cites·16 claims
- 4778US7947451B2Genetic polymorphisms associated with psoriasis, methods of detection and uses thereofCELERA CORP·Filed 2008·Granted May 24, 2011·2 cites·37 claims
- 4878US2023100271A1Genetic polymorphisms associated with cardiovascular diseases, methods of detection and uses thereofCELERA CORP·Filed 2022·Application pending·0 cites
- 4977US11814684B2Genetic polymorphisms associated with coronary events and drug response, methods of detection and uses thereofCELERA CORP·Filed 2021·Granted Nov 14, 2023·0 cites·20 claims
- 5077US10563263B2Genetic polymorphisms associated with statin response and cardiovascular diseases, methods of detection and uses thereofCELERA CORP·Filed 2018·Granted Feb 18, 2020·1 cites·4 claims
Showing the top 50 of 147 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →